Clinical Trial Update: Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reporting completion of a single-dose clamp study evaluating concentration-time profiles and metabolic activity of three dose leve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)
• Humalog (insulin lispro)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED